Clinical trials: Ipsilateral Supraclavicular Lymph Node Metastasis
Breast Cancer Stage III
Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer
Breast cancer patients with ipsilateral supraclavicular lymph node metastasis are defined as Ⅲc stage (N3) according to the newly published 8th AJCC TNM staging system. No concret guide line was supported to such patients.
- Trial name
- NCT03716245
- Testing
- supraclavicular lymph node dissection, supraclavicular area radiotherapy
- Where
- China
- Volunteers
- 180 people
- Sponsor
- Xinhong Wu, PhD
Breast Cancer, Ipsilateral Supraclavicular Lymph Node Metastasis
Supraclavicular Lymph Node Dissection for Ipsilateral Supraclavicular Lymph Node Metastatic Breast Cancer
The purpose of this study was to compare the efficacy of surgical dissection of supraclavicular lymph nodes combined with radiotherapy versus radiotherapy alone in patients with ipsilateral supraclavicular lymph node metastasis.
- Trial name
- NCT06383663
- Testing
- Supraclavicular lymph node dissection combined with radiotherapy, radiotherapy
- Volunteers
- 452 people
- Sponsor
- Sun Yat-sen University